Add a listing
    Add a listing

    Oncosence

      Inducing senescence in cancer cells and clearing them with senolytics

    General
    • Headquarters

      Plesmanlaan 121, 1066 CX Amsterdam, Netherlands

    • Founders & Team

      Rene Bernards, Andrea Alimonti

    • Year Founded

      2017

    • Company type

      Private company

    • Funding stage

      Seed

    Technical Details
    • Aging Target

      Cellular senescence

    • Product modality

      small molecule drugs

    About

    At Oncosence we target cancer by developing senescence inducing and senolytic (senescent cell killing) compounds.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In